Zawiejska Agnieszka, Wender-Ozegowska Ewa, Bogacz Anna, Iciek Rafal, Mikolajczak Przemyslaw, Brazert Jacek
Department of Reproduction, Karol Marcinkowski University of Medical Sciences, Poznan, Poland.
Ginekol Pol. 2018;89(12):705-710. doi: 10.5603/GP.a2018.0119.
We conducted a prospective observational study of a group of women (N = 140) in singleton pregnancies who delivered at term. Characteristics of the study group at enrolment: age: 32.0 ± 4.9 years; GA: 26.6 ± 7.5 weeks; HbA1c: 5.6 ± 0.6%; fasting blood glucose: 102.3 ± 16.3 mg/dL; insulin treatment (G2DM): 65.7%; chronic hypertension: 11.4%; gestational hypertension: 17.9%; preeclampsia: 1.4%; birth weight: 3590 ± 540 g; birth weight ≥ 4000 g (macrosomia): 18.6%; caesarean section: 44.3%; and female newborns: 57.1%.
The maternal metabolic characteristics at the time of booking did not differ between polymorphisms. Macrosomia was insignificantly more frequent in females (22.5%) than in males (13.3%) (p = 0.193). Only maternal height and body weight at the time of booking significantly predicted birth weight (R = 0.27, p = 0.007; R = 0.25, p = 0.005, respectively). IRS1 G972R GR and ENPP1 K121Q KQ polymorphisms were associated with an insignificantly increased risk for macrosomia. Carriers of the heterozygotic variant of the IRS 1 gene were significantly more likely to be diagnosed with GDM/DiP in the first trimester: OR 5.2, 95% CI: 1.4; 19.2; p = 0.014.
1)分析妊娠期糖尿病女性中2型糖尿病多态性所选候选基因(IRS1 G972R;ENPP1 K121Q;ADRB3 W64R)的流行情况;2)研究这些基因变异与新生儿巨大儿风险之间的任何关联。
我们对一组单胎足月分娩的女性(N = 140)进行了前瞻性观察研究。入组时研究组的特征:年龄:32.0±4.9岁;孕周:26.6±7.5周;糖化血红蛋白:5.6±0.6%;空腹血糖:102.3±16.3mg/dL;胰岛素治疗(妊娠期糖尿病):65.7%;慢性高血压:11.4%;妊娠期高血压:17.9%;先兆子痫:1.4%;出生体重:3590±540g;出生体重≥4000g(巨大儿):18.6%;剖宫产:44.3%;女婴:57.1%。
不同多态性之间,建档时的母亲代谢特征无差异。巨大儿在女性中的发生率(22.5%)略高于男性(13.3%),但差异无统计学意义(p = 0.193)。仅建档时的母亲身高和体重显著预测出生体重(R = 0.27,p = 0.007;R = 0.25,p = 0.005)。IRS1 G972R GR和ENPP1 K121Q KQ多态性与巨大儿风险略有增加相关。IRS 1基因杂合变异携带者在孕早期被诊断为妊娠期糖尿病/糖尿病前期的可能性显著更高:比值比5.2,95%置信区间:1.4;19.2;p = 0.014。
1)2型糖尿病候选基因特定变异的携带者具有相似的代谢特征,但其分娩巨大儿新生儿的风险可能增加;2)该人群中基因变异与巨大儿之间的任何关联可能具有性别特异性;3)IRS1基因的等位基因变异与早期妊娠期糖尿病/糖尿病前期相关。